Pravastatin is a medication used to manage and treat primary hypercholesterolemia, hyperlipidemia, and mixed dyslipidemia. It falls under the class of competitive hydroxymethylglutaryl coenzyme-A (HMG Co-A) reductase inhibitors. This activity reviews the indications, action, and contraindications for pravastatin as a valuable agent in treating and managing primary hypercholesterolemia, hyperlipidemia, and mixed dyslipidemia. This activity will highlight the mechanism of action, adverse effects, and other vital factors such as dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions pertinent for members of the interprofessional team in the treatment and care of patients with hyperlipidemia and related conditions.

**Objectives:**
- Identify the mechanism of action of pravastatin.
- Describe the potential adverse effects of pravastatin.
- Review the appropriate monitoring for a patient receiving therapy with pravastatin.
- Summarize interprofessional team strategies for improving care coordination and communication to advance pravastatin and improve outcomes.